Kulumbegov, B., Gotua, M., & Chikovani, T. (2023). Type I and Type IIb Autoimmunity in Chronic Spontaneous Urticaria Patients: Evaluating the Clinical Response to Omalizumab. Georgian Scientists, 5(2), 109–116. https://doi.org/10.52340/gs.2023.05.02.14